CLASS II Device recall · Reported 11 Sep 2019 · FDA Enforcement Report

ApeX acetabular liner hip prosthesis component ApeX-LNK recalled

OMNIlife science is recalling OMNIlife science, Inc. ApeX acetabular liner hip prosthesis component ApeX-LNK, distributed nationwide in the US. The recall was initiated on 23 Jul 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT # 31707
Quantity recalled6

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2481-2019
FDA event ID
83528
Recalling firm
OMNIlife science, Raynham, MA
Classification
Class II
Status
Terminated
Recall initiated
23 Jul 2019
FDA classified
5 Sep 2019
Reported
11 Sep 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

23 Jul 2019Recall initiated by company
5 Sep 2019Classified by FDA+44 days
11 Sep 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Acetabular liners failed the oxidation testing performed prior to release. They may experience a higher wear rate, leading to revision surgery.

Product as listed by the FDA

OMNIlife science, Inc. ApeX acetabular liner hip prosthesis component ApeX-LNK crosslinked Acetabular Insert, 10 deg hood; Product Code : H5-54840

Where it was distributed

US nationwide distribution to states of: IL, NY, OK, MD, AL, PA, CO, FL, and UT.

Nationwide AlabamaColoradoFloridaIllinoisMarylandNew YorkOklahomaPennsylvaniaUtah

Questions about this recall

Is ApeX acetabular liner hip prosthesis component ApeX-LNK crosslinked Acetabular Insert, 10 recalled?

Yes. OMNIlife science recalled ApeX acetabular liner hip prosthesis component ApeX-LNK crosslinked Acetabular Insert, 10 on 23 Jul 2019. The recall is Class II and its status is Terminated. Recall number Z-2481-2019.

Why was it recalled?

Acetabular liners failed the oxidation testing performed prior to release. They may experience a higher wear rate, leading to revision surgery.

Which lots are affected?

LOT # 31707

Where was it sold?

US nationwide distribution to states of: IL, NY, OK, MD, AL, PA, CO, FL, and UT.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from OMNIlife science

All 17

Other Hip & Knee Implants recalls

All 3,097